-
Dr Reddy's Labs Q3 Preview: Revlimid to dent US sales, profits may rise 12%
Source: Buzz FX / 20 Jan 2025 05:20:23 America/Chicago
Indian pharmaceutical (IT) major,
Dr Reddy’s Laboratories, is scheduled to deliver itsOctober-December quarterly earningsfor the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025. According to analyst estimates compiled by Busin
Read more...